Characteristics of circulating CD4+CD25+ regulatory T cells in chronic hepatitis B patients accepting antiviral therapy

Yan HUANG,De-ming TAN,Min-yuan PENG

DOI: https://doi.org/10.3969/j.issn.1671-9638.2009.06.002

2009-01-01

Abstract:Objective To investigate the characteristics of circulating CD4+CD25+regulatory T cells (Treg) in chronic hepatitis B (CHB) patients accepting peginterferon alfa-2a and adefovir therapy.Methods Peripheral blood mononuclear cells (PBMC) of 35 patients with CHB were collected at baseline and week 12,24 and 48 treatment. Eighteen patients were treated with peginterferon alfa-2a (40 KD) (PEGASYS) and 17 patients were treated with adefovir dipivoxil (ADV).Twelve healthy volunteers with normal liver function and negative hepatitis virus markers were as controls.The proportion of CD4+CD25+Treg/PBMC were analyzed using flow cytometry.The correlation between Treg and serum alanine transaminase(ALT) or HBV DNA was also analyzed.Results The proportion of Treg/PBMC in PEGASYS-treatment group and ADV-treatment group before treatment were (3.72+1.15) and (3.63+1.02) % respectively,which were significantly higher than that(2.47+0.90) % in healthy controls (t= 2.51,2.48;both P<0.05).In PEGASYS group,the proportion of CD4+CD25+Treg at week 12,24 and 48 treatment were (2.87+0.76) %,(2.75+0.72) % and (2.51+0.69) % respectively,which significantly decreased than that of baseline (t=2.41,2.58,2.95;P<0.05,<0.05,<0.01).No significant changes in CD4+CD25+ Treg were found in ADV treatment group before and after treatment(P>0.05).A strong correlation was observed between the change in ALT level and the proportion of CD4+CD25+Treg (r=0.52,P<0.01).No correlation was found between the change in HBV DNA and CD4+CD25+Treg(r=0.25,P>0.05).Conclusion The level of peripheral blood CD4+CD25+Treg in CHB patients is higher than that in healthy controls.PEGASYS antiviral treatment can decrease the proportion of CD4+CD25+Treg,while ADV antiviral treatment has no influence on CD4+CD25+Treg.